Solstice Pharma

Solstice Pharmaceuticals is a French radiopharmaceutical company specializing in the development and commercialization of automated systems for the production of short-lived isotopes used in PET imaging. The company's flagship technology, the Solstice system, provides a dose-on-demand solution for the point-of-care production of Oxygen-15 labeled water ([15O]H2O). As the gold standard for quantifying regional blood flow (perfusion), [15O]H2O is critical for clinical applications in oncology, cardiology, and neurology, but its two-minute half-life has historically limited its widespread use. Solstice Pharmaceuticals' platform overcomes these logistical barriers, enabling clinical centers to perform precise perfusion quantification and improve patient management in precision medicine.